BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14506139)

  • 1. Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.
    Tanyi JL; Hasegawa Y; Lapushin R; Morris AJ; Wolf JK; Berchuck A; Lu K; Smith DI; Kalli K; Hartmann LC; McCune K; Fishman D; Broaddus R; Cheng KW; Atkinson EN; Yamal JM; Bast RC; Felix EA; Newman RA; Mills GB
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3534-45. PubMed ID: 14506139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
    Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
    Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
    Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
    J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
    Hu YL; Albanese C; Pestell RG; Jaffe RB
    J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells.
    Zhao Y; Usatyuk PV; Cummings R; Saatian B; He D; Watkins T; Morris A; Spannhake EW; Brindley DN; Natarajan V
    Biochem J; 2005 Jan; 385(Pt 2):493-502. PubMed ID: 15461590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lysophosphatidic acid as a potential target for treatment and molecular diagnosis of epithelial ovarian cancers].
    Tanyi J; Rigó J
    Orv Hetil; 2009 Jun; 150(24):1109-18. PubMed ID: 19739275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent.
    Bermudez Y; Yang H; Saunders BO; Cheng JQ; Nicosia SV; Kruk PA
    Gynecol Oncol; 2007 Sep; 106(3):526-37. PubMed ID: 17559911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.
    Eder AM; Sasagawa T; Mao M; Aoki J; Mills GB
    Clin Cancer Res; 2000 Jun; 6(6):2482-91. PubMed ID: 10873103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
    Pustilnik TB; Estrella V; Wiener JR; Mao M; Eder A; Watt MA; Bast RC; Mills GB
    Clin Cancer Res; 1999 Nov; 5(11):3704-10. PubMed ID: 10589790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
    Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
    Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor.
    Chou CH; Wei LH; Kuo ML; Huang YJ; Lai KP; Chen CA; Hsieh CY
    Carcinogenesis; 2005 Jan; 26(1):45-52. PubMed ID: 15471896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells.
    Imai A; Furui T; Tamaya T; Mills GB
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3370-5. PubMed ID: 10999836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of lysophosphatidic acid receptor in human ovarian cancer cell lines 3AO, SKOV3, OVCAR3 and its significance].
    Wang P; Wu XH; Chen WX; Shan BE; Guo Q
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1422-4, 1431. PubMed ID: 16305971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia-inducible factor-1alpha and the PI3K pathway.
    Yang K; Zheng D; Deng X; Bai L; Xu Y; Cong YS
    J Cell Biochem; 2008 Dec; 105(5):1194-201. PubMed ID: 18802925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
    Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
    Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.
    Kim KS; Sengupta S; Berk M; Kwak YG; Escobar PF; Belinson J; Mok SC; Xu Y
    Cancer Res; 2006 Aug; 66(16):7983-90. PubMed ID: 16912173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular lipid metabolism influences the survival of ovarian cancer cells.
    Kuwata S; Ohkubo K; Kumamoto S; Yamaguchi N; Izuka N; Murota K; Tsujiuchi T; Iwamori M; Fukushima N
    Biochem Biophys Res Commun; 2013 Sep; 439(2):280-4. PubMed ID: 23973712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.
    Furui T; LaPushin R; Mao M; Khan H; Watt SR; Watt MA; Lu Y; Fang X; Tsutsui S; Siddik ZH; Bast RC; Mills GB
    Clin Cancer Res; 1999 Dec; 5(12):4308-18. PubMed ID: 10632375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.
    Schwartz BM; Hong G; Morrison BH; Wu W; Baudhuin LM; Xiao YJ; Mok SC; Xu Y
    Gynecol Oncol; 2001 May; 81(2):291-300. PubMed ID: 11330965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.
    Ren J; Xiao YJ; Singh LS; Zhao X; Zhao Z; Feng L; Rose TM; Prestwich GD; Xu Y
    Cancer Res; 2006 Mar; 66(6):3006-14. PubMed ID: 16540649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.